1,832 results on '"Brazier, John"'
Search Results
2. Development and Valuation of a Preference-Weighted Measure in Age-Related Macular Degeneration From the Vision Impairment in Low Luminance Questionnaire: A MACUSTAR Report
3. Discrete Choice Experiments in Health State Valuation: A Systematic Review of Progress and New Trends
4. Unmet Parenthood Goals, Health-Related Quality of Life and Apparent Irrationality: Understanding the Value of Treatments for Infertility
5. Hypothetical versus experienced health state valuation: a qualitative study of adult general public views and preferences
6. Using the Online Elicitation of Personal Utility Functions Approach to Derive a Patient-Based 5-Level Version of EQ-5D Value Set: A Study in 122 Patients With Rheumatic Diseases From Germany
7. Symptom burden in patients with idiopathic multicentric Castleman disease and its impact on daily life: an international patient and caregiver survey
8. Valuing the EQ Health and Wellbeing Short Using Time Trade-Off and a Discrete Choice Experiment: A Feasibility Study
9. Chemical Synthesis of Oligonucelotide Sequences: Phosphoramidite Chemistry
10. Development of the Cystic Fibrosis Questionnaire-Revised-8 Dimensions: Estimating Utilities From the Cystic Fibrosis Questionnaire-Revised
11. Deciding Between SF-6Dv2 Health States: A Think-Aloud Study of Decision-Making Strategies Used in Discrete Choice Experiments
12. Developing a New Generic Health and Wellbeing Measure: Psychometric Survey Results for the EQ-HWB
13. The EQ-HWB: Overview of the Development of a Measure of Health and Wellbeing and Key Results
14. Qualitative Review on Domains of Quality of Life Important for Patients, Social Care Users, and Informal Carers to Inform the Development of the EQ-HWB
15. Generation, Selection, and Face Validation of Items for a New Generic Measure of Quality of Life: The EQ-HWB
16. Development of the SF-6Dv2 health utility survey: comprehensibility and patient preference
17. Adapting preference-based utility measures to capture the impact of cancer treatment-related symptoms
18. Valuing SF-6Dv2 in Australia Using an International Protocol
19. Exploring health preference heterogeneity in the UK: Using the online elicitation of personal utility functions approach to construct EQ‐5D‐5L value functions on societal, group and individual level
20. Deriving a Preference-Based Measure for People With Duchenne Muscular Dystrophy From the DMD-QoL
21. Modelling a preference-based index for EQ-5D-3L and EQ-5D-3L + Sleep using a Bayesian framework
22. The Simplified Chinese version of SF-6Dv2 : translation, cross-cultural adaptation and preliminary psychometric testing
23. What is the best approach to adopt for identifying the domains for a new measure of health, social care and carer-related quality of life to measure quality-adjusted life years? Application to the development of the EQ-HWB?
24. A Comparison of the SF-6Dv2 and SF-6D UK Utility Values in a Mixed Patient and Healthy Population
25. Cost Effectiveness of Ranibizumab vs Aflibercept vs Bevacizumab for the Treatment of Macular Oedema Due to Central Retinal Vein Occlusion: The LEAVO Study
26. How to measure fluctuating impairments in people with MS: development of an ambulatory assessment version of the EQ-5D-5L in an exploratory study
27. Person-centred experiential therapy versus cognitive behavioural therapy delivered in the English Improving Access to Psychological Therapies service for the treatment of moderate or severe depression (PRaCTICED): a pragmatic, randomised, non-inferiority trial
28. Vignette-Based Utilities: Usefulness, Limitations, and Methodological Recommendations
29. Estimating a Preference-Based Index for Mental Health From the Recovering Quality of Life Measure: Valuation of Recovering Quality of Life Utility Index
30. Valuation of SF-6Dv2 Health States in China Using Time Trade-off and Discrete-Choice Experiment with a Duration Dimension
31. Criteria for item selection for a preference-based measure for use in economic evaluation
32. Do Discrete Choice Experiments Approaches Perform Better Than Time Trade-Off in Eliciting Health State Utilities? Evidence From SF-6Dv2 in China
33. Health State Utilities of Patients with Heart Failure: A Systematic Literature Review
34. An item response theory analysis of an item pool for the recovering quality of life (ReQoL) measure
35. Mapping From Visual Acuity to EQ-5D, EQ-5D With Vision Bolt-On, and VFQ-UI in Patients With Macular Edema in the LEAVO Trial
36. Are Current Reporting Standards Used to Describe Health State Utilities in Cost-Effectiveness Models Satisfactory?
37. Using the Online Elicitation of Personal Utility Functions (OPUF) approach to derive a patient-based EQ-5D-5L value set: a study in 122 patients with rheumatic diseases from Germany
38. The SF-6Dv2: How Does the New Classification System Impact the Distribution of Responses Compared with the Original SF-6D?
39. Exploring the item sets of the Recovering Quality of Life (ReQoL) measures using factor analysis
40. Valuing child and adolescent health: a qualitative study on different perspectives and priorities taken by the adult general public
41. Effect of Reflection and Deliberation on Health State Values: A Mixed-Methods Study
42. Consistency Between Three Different Ways of Administering the Short Form 6 Dimension Version 2
43. Identification, Review, and Use of Health State Utilities in Cost-Effectiveness Models: An ISPOR Good Practices for Outcomes Research Task Force Report
44. Selecting Bolt-On Dimensions for the EQ-5D: Examining Their Contribution to Health-Related Quality of Life
45. Future Directions in Valuing Benefits for Estimating QALYs: Is Time Up for the EQ-5D?
46. Measurement of Utilities Associated with Parenteral Support Requirement in Patients with Short Bowel Syndrome and Intestinal Failure
47. Development of a Preference-Based Index From the National Eye Institute Visual Function Questionnaire–25
48. United States Value Set for the Functional Assessment of Cancer Therapy-General Eight Dimensions (FACT-8D), a Cancer-Specific Preference-Based Quality of Life Instrument.
49. PB2708: SYMPTOM BURDEN AND ITS IMPACT ON DAILY LIFE IN PATIENTS WITH IDIOPATHIC MULTICENTRIC CASTLEMAN’S DISEASE (IMCD): AN EXPLORATORY ANALYSIS OF THE SURVEY’S INTERNAL CONSTRUCT VALIDITY
50. Experience-based utility and own health state valuation for a health state classification system: why and how to do it
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.